Clinical trial Recruiting at 1 site Observational Ages 18 and up

Genetic causes of spontaneous coronary artery dissection

Official title: Genetic Investigations in Spontaneous Coronary Artery Dissection (SCAD)

Run by Mayo Clinic · NCT01427179 · Data updated 2026-11-12

This project will test whether inherited or new gene changes cause spontaneous coronary artery dissection in adults with SCAD and their biological relatives.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment2000 (estimated)
SponsorMayo Clinic
Academic / other
Locations1 site (Rochester, Minnesota)
StatusRecruiting
StartedMay 2011
Main results expectedDecember 2028
Study endsDecember 2030
Registry record updatedApril 15, 2026
Trial IDNCT01427179 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with one or more confirmed episodes of SCAD who can give informed consent, and their biological parents or relatives with fibromuscular dysplasia, arterial aneurysm, or arterial dissection willing to provide samples.

Probably not a fit

People without angiographic confirmation of SCAD or those unable to provide informed consent or a blood/saliva sample are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The study creates a genomic DNA and plasma biobank from adults with angiographically confirmed SCAD and from their biological parents and affected relatives. Researchers will search for inherited and de novo mutations and look for common genetic variants that increase SCAD risk using genomic analyses. Participants are identified both retrospectively and prospectively, with diagnosis confirmed by coronary angiogram review before consent and sample collection. Long-term goals include defining molecular mechanisms and developing biomarkers to improve prediction and prevention of SCAD.

Why it matters

Potential benefit: If successful, this work could enable genetic tests and biomarkers to identify people at higher risk for SCAD and support family screening and prevention strategies.

How similar studies have gone: Some prior genetic and genome-wide studies have found risk loci suggesting a genetic contribution to SCAD, but comprehensive inherited and de novo mutation analysis remains relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Men and women able to give informed consent and complete a 2 page questionnaire
* Diagnosis of one or more episodes of spontaneous coronary artery dissection (SCAD)
* Biological parent of individual with SCAD
* Relative with fibromuscular dysplasia, arterial aneurysm, or arterial dissection

Exclusion Criteria:

* Lack of confirmation of SCAD diagnosis

Where it's running

  • Mayo Clinic
    Rochester, Minnesota, United States
    Recruiting

Study contacts

  • Principal investigator: Sharonne N. Hayes, M.D. — Mayo Clinic
  • Study coordinator: Jake Nemgar
  • Email: MayoSCAD@Mayo.edu
  • Phone: 5072663180

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.